top of page

MHRA Guidance: Registration & Regulating Medical Devices in UK

Writer's picture: Sharan MuruganSharan Murugan

Yesterday (28 April 2023) UK's Medicines and Healthcare Products Regulatory Agency (MHRA) released updated guidance on "Regulating medical devices in the UK" that provides detailed instructions on what you need to do to place a medical device in Great Britain, Northern Ireland and European Union (EU) markets.

Medical devices in the UK are regulated by the MHRA, and this guide includes information on the UK medical device regulatory system, such as:

  • getting your device certified

  • conformity marking your device

  • registering your device with the MHRA

This guidance pertains solely to in vitro diagnostic medical devices and active implantable medical devices and is limited to medical devices only. It does not encompass other CE or UKCA-marked products, as these are subject to distinct guidance.


The main purpose of updating this guidance was to incorporate a planned expansion of the acceptance of CE-marked medical devices on the Great Britain market, beyond the deadline of 30 June 2023.


At present, CE-marked medical devices with a valid CE marking can be placed on the Great Britain market until 30 June 2023, and the government intends to extend CE-marking acceptance beyond 30 June 2023.


Manufacturers wishing to sell medical devices in Great Britain now have access to a new route to market and product marking (the UKCA marking) starting on 1 January 2021. UKCA (UK Conformity Assessed) markings are used for certain goods, including medical devices, to appear on the Great Britain market (England, Wales, and Scotland). The UK Market Conformity Assessment Bodies (UKMCAB) database serves as the UK’s database of conformity assessment bodies.


Similarly, there were 2 more guidances that were related to Medical devices on 27th April, 2023


Comments


I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page